CDC deputy director to leave Trump administration, paper says

What happened

Jennifer Shuford, deputy director and chief medical officer of the US Centers for Disease Control and Prevention, will leave the Trump administration after next week's midterm elections, the Washington Post reported, citing sources. The CDC and White House did not comment.

Confirmed

Global impact / market context

A senior health official leaving during a vaccine policy shift can affect how companies plan production and how investors judge regulatory risk. Vaccine makers may face higher costs if they must split childhood shots into five separate doses, which means more packaging and distribution work.

Analyst inference

The reported departure adds uncertainty around US vaccine rules, which can shape revenue expectations for vaccine makers and suppliers. Investors may reprice regulatory risk in healthcare assets, while companies weigh changes to capital spending and production lines if dose-splitting plans proceed.

Analyst inference

What to watch

1. The Washington Post reported Shuford's departure after next week's midterm elections, citing sources, while the CDC and White House did not respond to requests for comment outside business hours. Confirmed
2. President Donald Trump unveiled plans to demand that vaccine makers split certain childhood shots into five separate doses, a step the article says would advance Health Secretary Robert F. Kennedy Jr.'s goal. Proposed
3. Watch whether vaccine makers disclose changes to production costs, capital spending, or revenue outlooks if dose-splitting proceeds, and whether other senior health officials also leave. Analyst inference

Evidence

• Original source link unavailable